diltiazem has been researched along with Thrombotic Microangiopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, K; Graham, DJ; Houstoun, M; Jones, SC; Kelman, JA; Lam, C; MaCurdy, TE; Nambiar, S; Reichman, ME; Shamsuddin, H; Wernecke, M; Worrall, CM | 1 |
1 other study(ies) available for diltiazem and Thrombotic Microangiopathies
Article | Year |
---|---|
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data.
Topics: Aged; Centers for Medicare and Medicaid Services, U.S.; Databases, Factual; Diltiazem; Drug Approval; Drug Labeling; Humans; Incidence; Malaria; Medicare; Muscle Cramp; Muscle Relaxants, Central; Purpura, Thrombocytopenic, Idiopathic; Quinine; Thrombotic Microangiopathies; United States; United States Food and Drug Administration | 2014 |